Literature DB >> 24566078

Revisiting the relationship between blood pressure and insulin-like growth factor-1.

Aletta Elisabeth Schutte1, Massimo Volpe, Giuliano Tocci, Elena Conti.   

Abstract

Conflicting evidence exists on the relationship between blood pressure (BP) and insulin-like growth factor-1 (IGF-1). We reviewed available articles and pooled extrapolated regression coefficients for the association between BP and total IGF-1 as reported in the literature and included additional data from 912 individuals from the general population. We identified 20 studies including 11 704 subjects. We also measured total IGF-1, insulin-like binding protein-3, and BP in 912 black and white men and women from South Africa (aged 20-70 years). When plotting positive and negative weighed regression coefficients (29 data points) against IGF-1, we found a significant positive relationship (r=0.31; P<0.001; n=11 704) intercepting the 0 point at 191 ng/mL IGF-1, suggesting an inverse BP/IGF-1 relationship in low IGF-1 conditions, and a positive relationship in overtly high IGF-1 conditions. In conclusion, our findings suggest that the relationship between BP and IGF-1 is dependent on, or related to, IGF-1 concentrations, as an expression of direct or reverse causality. Low IGF-1 bioavailability (associated with aging and vascular deterioration), resistance to IGF-1, and the complex interplay between IGF-1 and other vasoactive hormones could mask the vasoprotective functions of IGF-1 in cross-sectional studies or could modify their functions in prospective studies.

Entities:  

Keywords:  acromegaly; aging; hypertension; vasodilation

Mesh:

Substances:

Year:  2014        PMID: 24566078     DOI: 10.1161/HYPERTENSIONAHA.113.03057

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  14 in total

1.  Changes in metabolic parameters and cardiovascular risk factors after therapeutic control of acromegaly vary with the treatment modality. Data from the Bicêtre cohort, and review of the literature.

Authors:  Claire Briet; Mirela Diana Ilie; Emmanuelle Kuhn; Luigi Maione; Sylvie Brailly-Tabard; Sylvie Salenave; Bertrand Cariou; Philippe Chanson
Journal:  Endocrine       Date:  2018-11-05       Impact factor: 3.633

Review 2.  Cardiovascular comorbidities in acromegaly: an update on their diagnosis and management.

Authors:  Ana M Ramos-Leví; Mónica Marazuela
Journal:  Endocrine       Date:  2017-01-02       Impact factor: 3.633

3.  Novel mechanism of blood pressure regulation by forkhead box class O1-mediated transcriptional control of hepatic angiotensinogen.

Authors:  Yajuan Qi; Kebin Zhang; Yuxin Wu; Zihui Xu; Qian Chen Yong; Rajesh Kumar; Kenneth M Baker; Qinglei Zhu; Shouwen Chen; Shaodong Guo
Journal:  Hypertension       Date:  2014-07-28       Impact factor: 10.190

4.  Arterial properties in acromegaly: relation to disease activity and associated cardiovascular risk factors.

Authors:  Marianna Yaron; Elena Izkhakov; Jessica Sack; Ibrahim Azzam; Etty Osher; Karen Tordjman; Naftali Stern; Yona Greenman
Journal:  Pituitary       Date:  2016-06       Impact factor: 4.107

5.  Exogenous estrogen as mediator of racial differences in bioactive insulin-like growth factor-I levels among postmenopausal women.

Authors:  Su Yon Jung; Mara Z Vitolins; Electra D Paskett; Shine Chang
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-09-18       Impact factor: 6.053

6.  Prevalence of IGFBP3, NOS3 and TCF7L2 polymorphisms and their association with hypertension: a population-based study with Brazilian women of African descent.

Authors:  Abel Barbosa Lira Neto; Nancy Borges Rodrigues Vasconcelos; Tamara Rodrigues Dos Santos; Luisa Elvira Cavazzani Duarte; Monica Lopes Assunção; Carolinne de Sales-Marques; Haroldo da Silva Ferreira
Journal:  BMC Res Notes       Date:  2021-05-17

7.  Inflammation and oxidative stress markers in diabetes and hypertension.

Authors:  Chloé Pouvreau; Antoine Dayre; Eugene G Butkowski; Beverlie de Jong; Herbert F Jelinek
Journal:  J Inflamm Res       Date:  2018-02-19

Review 8.  Effects of somatostatin analog treatment on cardiovascular parameters in patients with acromegaly: A systematic review.

Authors:  Maryam Heidarpour; Davood Shafie; Ashraf Aminorroaya; Nizal Sarrafzadegan; Ziba Farajzadegan; Rasool Nouri; Arash Najimi; Christina Dimopolou; Gunter Stalla
Journal:  J Res Med Sci       Date:  2019-04-26       Impact factor: 1.852

9.  Association between polymorphism at IGF-1 rs35767 gene locus and long-term decline in renal function: a Japanese retrospective longitudinal cohort study.

Authors:  Kosuke Honda; Satoru Kuriyama; Kimiyoshi Ichida; Tomoko Nakano; Naoki Sugano; Takashi Yokoo
Journal:  BMC Nephrol       Date:  2021-06-02       Impact factor: 2.388

10.  The Prospective Association Between Plasma Concentrations of Cellular Growth Factors and Risk of Heart Failure Mortality in Japanese Population.

Authors:  Ehab S Eshak; Koutatsu Maruyama; Hiroyasu Iso; Akiko Tamakoshi
Journal:  J Epidemiol       Date:  2018-08-04       Impact factor: 3.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.